For Your Kitchen
Cookbooks

Everyday recipes with room for flavor, variety, and real life. Dinner should not feel like homework.

Taste it

Sponsorship complete. Dine on...

Nutrition, wellness, weight loss, and calmer healthy living.

Study Reveals How GLP-1 Drugs May Reduce Pleasure-Driven Eating

Jul 26, 2026
Study Reveals How GLP-1 Drugs May Reduce Pleasure-Driven Eating

Recent research funded by the National Institutes of Health (NIH) has shed light on the effects of newer oral GLP-1 medications, such as orforglipron and danuglipron, on the brain's reward circuits. These drugs, part of a class that includes well-known weight-loss and diabetes medications like semaglutide and Ozempic, have been shown to reduce hedonic feeding—eating for enjoyment rather than energy needs—in mice. This study highlights a previously unrecognized pathway through which these medications may influence eating behavior.

The research team from the University of Virginia focused on small-molecule GLP-1 receptor agonists, which differ from larger peptide medications. The study aimed to understand how these oral drugs interact with the brain, particularly in areas related to pleasure and reward. The findings revealed that while these medications affect regions associated with appetite regulation, they also activate the central amygdala, a deeper brain region involved in desire and reward. This activation appears to suppress dopamine release in key areas of the brain's reward system during pleasure-driven eating.

For Your Kitchen
Cookbooks
Taste it
Kitchen Scales
Taste it
Meal Prep Containers
Taste it

Sponsorship complete. Dine on...

Dr. Lorenzo Leggio, Clinical Director of NIH's National Institute on Drug Abuse, emphasized the importance of understanding the neural mechanisms behind these medications as their accessibility increases. The study suggests that oral GLP-1 drugs may not only curb hunger but also diminish the pleasurable signals that make certain foods appealing.

As researchers continue to explore the implications of these findings, they aim to investigate whether these next-generation GLP-1 medications could also help reduce cravings for substances beyond food, potentially addressing issues related to substance use disorders. The study was supported by various NIH grants and is not yet associated with clinical trials for product approval.

For Your Kitchen
Cookbooks
Taste it
Kitchen Scales
Taste it
Meal Prep Containers
Taste it
Vegetable Prep & Salad Spinners
Taste it

Sponsorship complete. Dine on...

For Your Kitchen
Cookbooks

Everyday recipes with room for flavor, variety, and real life. Dinner should not feel like homework.

Taste it
Kitchen Scales

Kitchen scales for recipes that deserve more precision than 'that looks about right.'

Taste it
Meal Prep Containers

Give tomorrow's lunch a proper home. Containers for meals worth looking forward to.

Taste it
Vegetable Prep & Salad Spinners

Salad spinners and vegetable-prep tools for everyday salads, bowls, and side dishes. A little less kitchen setup, a little more time to enjoy the meal.

Taste it
Blenders & Smoothie Tools

Blenders for fruit, yogurt, soups, and the combinations you actually enjoy. Everyday kitchen tools, not a promise in a glass.

Taste it
Sheet Pans & Roasting Essentials

Sheet pans and roasting racks for vegetables and simple oven meals. Useful equipment for dinner without an elaborate production.

Taste it

Sponsorship complete. Dine on...

Across our publications

In Other News

Latest stories from other publications.

Explore all publications (opens in a new tab)